peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

non-peptide ghrelin mimetic / GHSR agonist

MK-677

Published evidence · coverage incomplete
Anatomical contextAnatomy connections are not mapped yet.

No body region is highlighted until this profile has a supported anatomical connection. This does not mean the peptide has no biological effects.

Read published mechanism findings ↓

At a glance

What is it—and why does it matter?

MK-677 was one of the emerging peptides targeted for evidence synthesis regarding musculoskeletal recovery and performance enhancement across animal and human models.

Sources for this introduction: [1]

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

How does it work?

Target, response, and disposition.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

What has been studied?

What the evidence says.

Study findings

MK-677 was one of the emerging peptides targeted for evidence synthesis regarding musculoskeletal recovery and performance enhancement across animal and human models.

Sources[1]pubmedPeptide Supplements and Their Therapeutic Applications in Sports Medicine.To summarize existing peer-reviewed data on 6 emerging peptides (BPC-157, thymosin beta-4 or TB-500, CJC-1295, MK-677, ipamorelin, and GHK-Cu [copper peptide]) for musculoskeletal recovery and enhancement in animal and human models.
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “To summarize existing peer-reviewed data on 6 emerging peptides (BPC-157, thymosin beta-4 or TB-500, CJC-1295, MK-677, ipamorelin, and GHK-Cu [copper peptide]) for musculoskeletal recovery and enhancement in animal and human models.”

    Peptide Supplements and Their Therapeutic Applications in Sports Medicine. · PURPOSE

    pubmed:42578445:9b8b12ec3690:9b8b12ec3690

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, identity, interaction, mechanism, regulatory, safety
  • 3 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (1), assurance_score_below_0.72 (2), current_regulatory_source_required (1), extraction_ambiguity (3), high_risk_requires_regulatory_or_two_independent_sources (2), no_direct_support (3)

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. Peptide Supplements and Their Therapeutic Applications in Sports Medicine. ↗

    pubmed · published 2026-08-11 · retrieved 2026-08-25T22:58:23Z

Publication history and provenance

Version 2 · Automated assessment · 2026-08-25T22:58:23Z

04a642dea0ce8d088fdfd67fa06a09fbf2e5889537951e037f18530b3b62db45